STOCK TITAN

Waldencast plc - $WALD STOCK NEWS

Welcome to our dedicated page for Waldencast plc news (Ticker: $WALD), a resource for investors and traders seeking the latest updates and insights on Waldencast plc stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Waldencast plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Waldencast plc's position in the market.

Rhea-AI Summary

Waldencast plc, a global multi-brand beauty and wellness platform, will participate in the CreatorIQ Connect Europe conference in London on May 2, 2024. Founder and CEO Michel Brousset will discuss building legacy brands with industry leaders. The event aims to explore creator marketing strategies in the beauty industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
none
-
Rhea-AI Summary

Waldencast plc reported a successful fiscal year 2023 with net revenue of $218.1 million, a 15.3% increase from 2022. Group combined comparable revenue reached $212.5 million, and adjusted EBITDA improved to $24.4 million. Obagi Skincare saw revenue growth excluding Southeast Asia, while Milk Makeup excelled with revenue of $100.5 million. The company expects a 20% growth in Q1 2024 and an expansion in adjusted EBITDA margin for FY2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.94%
Tags
-
Rhea-AI Summary
Waldencast plc (NASDAQ: WALD) has regained compliance with Nasdaq's filing requirements, avoiding potential delisting. The company received formal notice from the Nasdaq Hearings Panel confirming compliance with the Periodic Filing Rule after filing financial results for the interim period ended June 30, 2023. A 'Mandatory Panel Monitor' has been imposed for one year to ensure continued compliance. Waldencast sees this as a significant achievement and plans to provide updates on its fiscal year 2023 performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
none
Rhea-AI Summary
Waldencast plc reports H1’23 Total Net Revenue of $109.3 million, Combined Adjusted EBITDA of $13.9 million, and introduces guidance for the future. The company's Founder and CEO, Michel Brousset, highlighted the strong performance of Milk Makeup with significant revenue growth, while Obagi Skincare faced challenges due to restructuring and delays in Southeast Asia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
-
Rhea-AI Summary
Obagi, a leader in skincare innovation, under Waldencast plc, launches Daily Hydro-Drops® Rejuvenating Eye Gel Cream to target delicate eye skin. The product promises hydration, brightness, and reduced puffiness. Formulated with clinically proven ingredients, it aims to address key skin concerns around the eyes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.17%
Tags
none
-
Rhea-AI Summary
Waldencast plc (NASDAQ: WALD) secures continued listing on Nasdaq following a decision by a Nasdaq Hearings Panel. The company must file interim financial statements by April 1, 2024, to maintain compliance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
Rhea-AI Summary
Waldencast plc appoints Mazdack Rassi as Global Brand Director to lead the newly formed Creative Council, aiming to drive innovation and stay ahead in the beauty and wellness industry. Rassi, along with a team of industry disruptors, will focus on shaping the future of Waldencast by identifying trends and fostering creativity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.4%
Tags
none
-
Rhea-AI Summary
Obagi Cosmeceuticals LLC appoints Dr. Suzan Obagi as Chief Medical Director, a renowned dermatologist and cosmetic surgeon, to drive product development and innovation. Obagi, a subsidiary of Waldencast plc (NASDAQ: WALD), aims to enhance its skincare solutions and maintain its leadership position in the industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.79%
Tags
none
-
Rhea-AI Summary
Waldencast plc (NASDAQ: WALD) announced its participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit on February 13, 2024. Founder and CEO Michel Brousset will host a fireside chat presentation and meet with investors throughout the day. The presentation will be webcast live and available for replay on the Company’s Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
none
Rhea-AI Summary
Waldencast plc announced the appointment of Manuel Manfredi as Chief Financial Officer, effective April 1, 2024, replacing Philippe Gautier. Manfredi brings 25 years of experience in the beauty and consumer products industries, with a proven track record at L’Oréal. Founder and CEO, Michel Brousset, expressed confidence in Manfredi's ability to drive financial rigor, growth, and profitability. The outgoing CFO, Philippe Gautier, was credited for strengthening the financial team and internal controls at Waldencast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.36%
Tags
none
Waldencast plc

Nasdaq:WALD

WALD Rankings

WALD Stock Data

597.50M
11.26M
56.65%
37.91%
0.57%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
United States of America
WHITE PLAINS